2007
DOI: 10.1002/art.23107
|View full text |Cite
|
Sign up to set email alerts
|

Potential treatment of calciphylaxis with vitamin K2: Comment on the article by Jacobs‐Kosmin and DeHoratius

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
5
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 18 publications
0
5
0
Order By: Relevance
“…Although there are several reports mentioning the potential of prostacyclin and vitamin K 2 as well as bisphosphonate as therapeutic options for the disease (29-31), the present case did not allow us to precisely assess the clinical benefit of individual agents. Rather, the current report may emphasize the pitfalls of managing patients with NS who are subjected to warfarinization.…”
Section: Discussionmentioning
confidence: 66%
See 1 more Smart Citation
“…Although there are several reports mentioning the potential of prostacyclin and vitamin K 2 as well as bisphosphonate as therapeutic options for the disease (29-31), the present case did not allow us to precisely assess the clinical benefit of individual agents. Rather, the current report may emphasize the pitfalls of managing patients with NS who are subjected to warfarinization.…”
Section: Discussionmentioning
confidence: 66%
“…Despite the accumulation of anecdotal or systemic studies disclosing the nature of calciphylaxis ( 1 , 2 , 4 , 13 - 17 , 27 ), we feel that the ability to accurately diagnose the disease in the early stage and awareness of the disease itself remain challenges that must still be overcome by physicians. Although there are several reports mentioning the potential of prostacyclin and vitamin K 2 as well as bisphosphonate as therapeutic options for the disease ( 29 - 31 ), the present case did not allow us to precisely assess the clinical benefit of individual agents. Rather, the current report may emphasize the pitfalls of managing patients with NS who are subjected to warfarinization.…”
Section: Discussionmentioning
confidence: 66%
“…41 There has been literature on different treatment modalities like bisphosphonates, vitamin K, low-density lipoprotein apheresis, low-dose tissue plasminogen activator infusion, but these should be considered on an individual basis. [42][43][44][45] The data from a large nationwide registry in management of calciphylaxis are summarized in Table 5. 46 The wound healing based on case reports and case series in cohort studies using different strategies as discussed above are summarized in Table 6.…”
Section: Discussionmentioning
confidence: 99%
“…Studies on the actions of STS have noted direct vascular calcification inhibition, reduction in oxidative stress, and vasodilatory properties [ 44 , 45 , 46 ]. Other therapeutic options include intralesional STS, hyperbaric oxygen [ 1 ], bisphosphonates [ 47 ], cinacalcet [ 48 , 49 ], tissue plasminogen activator [ 50 ], sterile maggot therapy [ 51 ], vitamin K supplementation [ 52 ], low-density lipoprotein apheresis [ 53 ], and kidney transplantation [ 54 ]. Case reports suggest a benefit from treating abnormalities of calcium and phosphorus [ 55 , 56 , 57 , 58 ] and elevated parathyroid hormone [ 49 , 59 , 60 ].…”
Section: Discussionmentioning
confidence: 99%